These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24992986)

  • 1. Pathogenesis and histopathology of pertussis: implications for immunization.
    Cherry JD; Paddock CD
    Expert Rev Vaccines; 2014 Sep; 13(9):1115-23. PubMed ID: 24992986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 3. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal pertussis, cocooning and maternal immunization.
    Swamy GK; Wheeler SM
    Expert Rev Vaccines; 2014 Sep; 13(9):1107-14. PubMed ID: 25075629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concept of pertussis as a toxin-mediated disease.
    Pittman M
    Pediatr Infect Dis; 1984; 3(5):467-86. PubMed ID: 6093069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public health. The pertussis paradox.
    Allen A
    Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
    [No Abstract]   [Full Text] [Related]  

  • 9. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine.
    Robbel L; Hungerer KD; Aktories K
    Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental whooping cough of nonhuman primate].
    Kubrava DT; Medkova AIu; Siniashina LN; Shevtsova ZV; Matua AZ; Kondzharia IG; Barkaia VS; Elistratova ZhV; Karataev GI; Mikvabia ZIa; Gintsburg AL
    Vestn Ross Akad Med Nauk; 2013; (8):28-33. PubMed ID: 24340642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JMM Profile:
    Fry NK; Campbell H; Amirthalingam G
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The virulence factors of Bordetella pertussis: talented modulators of host immune response.
    Fedele G; Bianco M; Ausiello CM
    Arch Immunol Ther Exp (Warsz); 2013 Dec; 61(6):445-57. PubMed ID: 23955529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of improved pertussis vaccine.
    Rumbo M; Hozbor D
    Hum Vaccin Immunother; 2014; 10(8):2450-3. PubMed ID: 25424954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis from functional genomics to intranasal vaccination.
    Locht C; Antoine R; Raze D; Mielcarek N; Hot D; Lemoine Y; Mascart F
    Int J Med Microbiol; 2004 Apr; 293(7-8):583-8. PubMed ID: 15149035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acellular anti-pertussis vaccine].
    Bégué P; Grimpel E; Baron S
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):859-65. PubMed ID: 1819434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.
    Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C
    PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.